Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of ID110521156 in healthy adult subjects. This is the first clinical study of ID110521156.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
36 participants in 4 patient groups
Loading...
Central trial contact
Clinical Ops Study Leader
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal